| abstract |
The present invention relates to naphthyridine kinase modulators, their preparation and use as medicaments for regulating misdirected cell signal transduction processes, in particular for affecting tyrosine and serine-threonine kinases Function and use in the treatment of malignant or benign tumors, and other diseases based on pathological cell proliferation, for example, restenosis, psoriasis, arteriosclerosis and liver cirrhosis. |